Business and Career Development Coach for Lawyers | Former Harvard Law School Advisor | 25-Year BigLaw Partner
When (1) your company is a stand-in for the Danish economy, (2) you've dethroned LVMH (Louis Vuitton, Moët Hennessy, and countless "Maisons" if you must know) as the biggest company in Europe, (3) your '23 operating profit has grown 40-46%, (4) the global market for obesity and anti-diabetes drugs is beyond exploding, and (5) Wegovy and Ozempic appear to be only the beginning of a wave of promising applications for semaglutide... well, then you can do whatever you want, including threaten the EU to decamp pretty much altogether in response to new rules reducing guaranteed exclusivity. #bigpharma